Guanfacine
Sujin Lee Weinstein, PharmD, BCPP
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Attention deficit hyperactivity disorder (ADHD)
in pediatric patients (
>
6 years old), as monotherapy or adjunctive therapy with stimulants
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Autism spectrum disorder
,
post traumatic stress disorder
,
Tourette’s syndrome
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.